Family-Based Treatment for Type 1 Diabetes

Description

Type 1 Diabetes carries high burden for affected youth and their families. Advances in insulin therapy and technology have been associated with increased obesity with 1/3 adolescents being overweight/obese. Since obesity runs in families and carries risk for poor outcomes psychologically and medically, the investigators are adapting our successful evidence-based Family Based Treatment for hybrid delivery to improve obesity and metabolic control in the affected youth and improve obesity and related co-morbidities in their parents.

Conditions

Diabetes Mellitus, Type 1, Obesity, Childhood, Overweight, Comorbidities and Coexisting Conditions

Talk to us

Study Overview

On this page

Study Details

Study overview

Type 1 Diabetes carries high burden for affected youth and their families. Advances in insulin therapy and technology have been associated with increased obesity with 1/3 adolescents being overweight/obese. Since obesity runs in families and carries risk for poor outcomes psychologically and medically, the investigators are adapting our successful evidence-based Family Based Treatment for hybrid delivery to improve obesity and metabolic control in the affected youth and improve obesity and related co-morbidities in their parents.

A Family-Based Approach to Treat Obesity and Its Co-morbidities in Youth With Type 1 Diabetes (T1D) and Their Parents

Family-Based Treatment for Type 1 Diabetes

Condition
Diabetes Mellitus, Type 1
Intervention / Treatment

-

Contacts and Locations

Buffalo

Conventus, Buffalo, New York, United States, 14203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * T1D of 12 or more months duration
  • * Age 6-17-years
  • * Presence of overweight/obesity
  • * Youth uses a pump for insulin delivery and a continuous glucose monitoring device to monitor glycemic levels
  • * Youth has one parent with overweight/obesity willing to participate in the program
  • * Child:
  • * Chronic conditions other than T1D
  • * Other autoimmune conditions other then T1D or autoimmune thyroiditis.
  • * Medications that can affects weight, such as medications used to treat Attention Deficit Disorder or high dose steroids used to treat asthma.
  • * Depression symptoms by standard of care Patient Health Questionnaire (PHQ) 9 in the child or parent
  • * Inability to perform at least mild physical activity such as walking
  • * Child with handicap (such as developmental delay or deafness) that would prevent him/her from benefitting from counseling in person and/or remotely Participating parent with
  • * symptoms of depression assessed by standard of care PHQ
  • * autoimmune disorders other than T1D or autoimmune thyroiditis
  • * Participating parents with chronic disorder that is treated with medications that interfere with weight loss or are preventing him/her from performing at least mild physical activity

Ages Eligible for Study

6 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

State University of New York at Buffalo,

Study Record Dates

2024-12-31